Long-term follow-up of a randomized trial on 118 patients with polyarteritis nodosa or microscopic polyangiitis without poor-prognosis factors

Autoimmunity Reviews

Volumn 13, Issue 2, 2014, Pages 197-205

  Samson, Maxime ^a,b   Puéchal, Xavier ^a   Devilliers, Hervé ^b   Ribi, Camillo ^c   Cohen, Pascal ^a   Bienvenu, Boris ^d   Ruivard, Marc ^e   Terrier, Benjamin ^a   Pagnoux, Christian ^a,au   Mouthon, Luc ^a   Guillevin, Loïc ^a   Alcalay, Michel ^f   Arnal, Christophe ^g   Battesti, Jean Paul ^h   Bernardeau, Christophe ⁱ   Boullanger, Nadine ^j   Sao, Anne Buu ^h   Buzon, Jean Jacques ^k   Cabane, Jean ^l   Cacoub, Patrice ^m   Cantagrel, Alain ⁿ   Cevallos, Ramiro ^k   Charbonneau, Jacques ^k   Costedoat, Nathalie ^a   Créange, Alain ^o   Dadoniene, Jolanta ^p   de Faucal, Philippe ^q   Defuentes, Gilles ^r   de Seze, Jérôme ^s   Delaunay, Claire ^k   Dubertret, Louis ^t   Dubois, Alain ^u   Duhamel, Elisabeth ^k   Neau, Didier ^v   Estève, Eric ^k   Fior, Renato ^w   Foullon, Pierre ^x   Gaida, Tsouria ^v   Galperine, Tatjana ^v   Garcin, Jean Marie ^y   Gil, Helder ^z   Gilson, Brigitte ^k   Girard, Thomas ^w   Godeau, Bertrand ^o   Godmer, Pascal ^k   Gueit, Isabelle ^k   Hamidou, Mohamed ^aa   Labussière, Anne Sophie ^ab   Landron, Cédric ^f   Lanoux, Patricia ^k   Le Berruyer, Pierre Yves ^ac   Lhote, François ^ad   Lidove, Olivier ^ae   Loustaud Ratti, Véronique ^af   Maillard, Hervé ^k   Mejjad, Othmane ^k   Miossec, Pierre ^ag   Paris, Jean François ^ah   Penalba, Christian ^k   Pertuiset, Edouard ^k   Philippe, Jean Michel ^k   Ponge, Thierry ^ai   Quéré, Isabelle ^aj   Randrianjohany, Andry ^h   Rankin, Elizabeth ^ak   Saraux, Jean Luc ^al   Schaeffer, Annette ^o   Schmidt, Claude ^am   Schneebeli, Stéphane ^k   Seigneuric, Christian ^k   Smail, Amar ^an   Sparsa, Agnès ^af   Stirnemann, Jérôme ^ao   Swiader, Laure ^ap   Taillandier, Jean Pierre ^aq   Thévenot, Corinne ^k   Tiev, Kiet Phong ^l   Tolédano, Cécile ^t   Velmans, Nicolas ^k   Viallard, Jean François ^ar   Vidal, Elisabeth ^af   Wahl, Denis ^am   Wattiaux, Marie José ^l   Witte, Arnold ^k   Ziza, Jean Marc ^as   Zoulim, Abdelkader ^at   Bergère, Alain ^k   more..

^a Hôpital Cochin AP HP Université Paris Descartes ^*  (France)

^b HÔPITAL DU BOCAGE   (France)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d CHU CÔTE DE NACRE   (France)

^e UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^f POITIERS UNIVERSITY HOSPITAL   (France)

^g HÔPITAL TENON   (France)

^h AVICENNE HOSPITAL   (France)

ⁱ HÔPITAL LARIBOISIÈRE   (France)

^j Centre Hospitalier General   (France)

^k Centre Hospitalier ^*  (France)

^l HÔPITAL SAINT ANTOINE   (France)

^m PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

ⁿ CHU RANGUEIL   (France)

^o HENRI MONDOR HOSPITAL   (France)

^p VILNIUS UNIVERSITY   (Lithuania)

^q Nouvelles Cliniques Nantaises   (France)

^r PERCY MILITARY HOSPITAL   (France)

^s LILLE UNIVERSITY HOSPITAL   (France)

^t SAINT LOUIS HOSPITAL   (France)

^u Clinique mutualiste Beausoleil   (France)

^v HÔPITAL PELLEGRIN   (France)

^w HÔPITAL ANTOINE BÉCLÈRE   (France)

^x CH Dracénie   (France)

^y SERVICE D ENDOCRINOLOGIE   (France)

^z UNIVERSITY HOSPITAL OF BESANÇON   (France)

^aa HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^ab Jacques Coeur Hospital   (France)

^ac SERVICE DE DERMATOLOGIE   (France)

^ad Hospital Delafontaine   (France)

^ae BICHAT HOSPITAL   (France)

^af DUPUYTREN UNIVERSITY HOSPITAL   (France)

^ag EDOUARD HERRIOT HOSPITAL   (France)

^ah Military Teaching Hospital Sainte Anne   (France)

^ai HÔTEL DIEU   (France)

^aj HÔPITAL SAINT ELOI   (France)

^ak UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^al CH de Montmorency   (France)

^am UNIVERSITY HOSPITAL OF NANCY   (France)

^an AMIENS UNIVERSITY HOSPITAL   (France)

^ao HÔPITAL JEAN VERDIER   (France)

^ap TIMONE HOSPITAL   (France)

^aq HÔPITAL PAUL BROUSSE   (France)

^ar HAUT LÉVÊQUE HOSPITAL   (France)

^as CH de la Croix Saint Simon   (France)

^at CAEN UNIVERSITY HOSPITAL   (France)

^au UNIVERSITY HEALTH NETWORK   (Canada)

more..

Author keywords

ANCA; Long term follow up; Microscopic polyangiitis; Polyarteritis nodosa; Relapses; Sequelae

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; COLCHICINE; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN G; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE;

ADULT; CAUSE OF DEATH; CLINICAL FEATURE; CONCURRENT INFECTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; OSTEOPOROSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; PLASMAPHERESIS; POLYARTERITIS NODOSA; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; REVIEW; SCORING SYSTEM; SKIN DEFECT; SURVIVAL RATE; TREATMENT DURATION; TREATMENT RESPONSE; URINARY TRACT CANCER;

ANCA; LONG-TERM FOLLOW-UP; MICROSCOPIC POLYANGIITIS; POLYARTERITIS NODOSA; RELAPSES; SEQUELAE;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MICROSCOPIC POLYANGIITIS; MIDDLE AGED; POLYARTERITIS NODOSA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; SURVIVAL ANALYSIS;

EID: 84887988374     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2013.10.001     Document Type: Review

References (33)

1. Guillevin L., Mahr A., Callard P., Godmer P., Pagnoux C., Leray E., et al. Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 2005, 84:313-322.
2. Ribi C., Cohen P., Pagnoux C., Mahr A., Arène J.P., Puéchal X., et al. Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: a prospective randomized study of one hundred twenty-four patients. Arthritis Rheum 2010, 62:1186-1197.
3. Jennette J.C., Falk R.J., Bacon P.A., Basu N., Cid M.C., Ferrario F., et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013, 65:1-11.
4. Pagnoux C., Seror R., Henegar C., Mahr A., Cohen P., Le Guern V., et al. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum 2010, 62:616-626.
5. Guillevin L., Durand-Gasselin B., Cevallos R., Gayraud M., Lhote F., Callard P., et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999, 42:421-430.
6. Radice A., Bianchi L., Sinico R.A. Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis. Autoimmun Rev 2013, 12:487-495.
7. Villiger P.M., Guillevin L. Microscopic polyangiitis: clinical presentation. Autoimmun Rev 2010, 9:812-819.
8. Guillevin L., Lhote F., Gayraud M., Cohen P., Jarrousse B., Lortholary O., et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 1996, 75:17-28.
9. Guillevin L., Pagnoux C., Seror R., Mahr A., Mouthon L., Le Toumelin P. The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore) 2011, 90:19-27.
10. Lightfoot R.W., Michel B.A., Bloch D.A., Hunder G.G., Zvaifler N.J., McShane D.J., et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990, 33:1088-1093.
11. Jayne D.R., Rasmussen N. Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group. Mayo Clin Proc 1997, 72:737-747.
12. Luqmani R.A., Bacon P.A., Moots R.J., Janssen B.A., Pall A., Emery P., et al. Birmingham vasculitis activity score (BVAS) in systemic necrotizing vasculitis. QJM 1994, 87:671-678.
13. Exley A.R., Bacon P.A., Luqmani R.A., Kitas G.D., Gordon C., Savage C.O., et al. Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 1997, 40:371-380.
14. Hagen E.C., Andrassy K., Chernok E., Daha M.R., Gaskin G., Gross W., et al. The value of indirect immunofluorescence and solid phase techniques for ANCA detection. A report on the first phase of an international cooperative study on the standardization of ANCA assays. EEC/BCR Group for ANCA Assay Standardization. J Immunol Methods 1993, 159:1-16.
15. Hellmich B., Flossmann O., Gross W.L., Bacon P., Cohen-Tervaert J.W., Guillevin L., et al. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 2007, 66:605-617.
16. Hiemstra T.F., Walsh M., Mahr A., Savage C.O., de Groot K., Harper L., et al. Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial. JAMA 2010, 304:2381-2388.
17. Guillevin L. How to treat systemic necrotizing vasculitides?. Presse Med 2012, 41:1024-1030.
18. Pagnoux C., Quemeneur T., Ninet J., Perrodeau E., Diot E., Kyndt X., et al. Treatment of systemic necrotizing vasculitides in patients≥65years old: results of the multicenter randomized CORTAGE trial. Presse Med 2013, 42:679-680.
19. Walsh M., Merkel P.A., Mahr A., Jayne D. Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis. Arthritis Care Res (Hoboken) 2010, 62:1166-1173.
20. Mukhtyar C., Guillevin L., Cid M.C., Dasgupta B., de Groot K., Gross W., et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 2009, 68:310-317.
21. Holle J.U., Gross W.L. Treatment of ANCA-associated vasculitides (AAV). Autoimmun Rev 2013, 12:483-486.
22. Gayraud M., Guillevin L., Cohen P., Lhote F., Cacoub P., Deblois P., et al. Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides. Br J Rheumatol 1997, 36:1290-1297.
23. Le Guenno G., Mahr A., Pagnoux C., Dhote R., Guillevin L. Incidence and predictors of urotoxic adverse events in cyclophosphamide-treated patients with systemic necrotizing vasculitides. Arthritis Rheum 2011, 63:1435-1445.
24. Henegar C., Pagnoux C., Puechal X., Zucker J.D., Bar-Hen A., Le Guern V., et al. A paradigm of diagnostic criteria for polyarteritis nodosa: analysis of a series of 949 patients with vasculitides. Arthritis Rheum 2008, 58:1528-1538.
25. Gibson A., Stamp L.K., Chapman P.T., O'Donnell J.L. The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region. Rheumatology (Oxford) 2006, 45:624-628.
26. Hauer H.A., Bajema I.M., Van Houwelingen H.C., Ferrario F., Noel L.H., Waldherr R., et al. Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients. Kidney Int 2002, 62:1732-1742.
27. Pavone L., Grasselli C., Chierici E., Maggiore U., Garini G., Ronda N., et al. Outcome and prognostic factors during the course of primary small-vessel vasculitides. J Rheumatol 2006, 33:1299-1306.
28. Weidner S., Geuss S., Hafezi-Rachti S., Wonka A., Rupprecht H.D. ANCA-associated vasculitis with renal involvement: an outcome analysis. Nephrol Dial Transplant 2004, 19:1403-1411.
29. Perichon S., Pagnoux C., Seror R., Dassonville L., Mangouka L., Cohen P., et al. Periostitis in systemic necrotizing vasculitides: study of the 4 cases identified among the 1762 patients of the FVSG database and review of the literature. Presse Med 2010, 39:e165-e173.
30. Gayraud M., Guillevin L., le Toumelin P., Cohen P., Lhote F., Casassus P., et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 2001, 44:666-675.
31. Gordon M., Luqmani R.A., Adu D., Greaves I., Richards N., Michael J., et al. Necrotizing vasculitis-relapse despite cytotoxic therapy. Adv Exp Med Biol 1993, 336:477-481.
32. Savage C.O., Winearls C.G., Evans D.J., Rees A.J., Lockwood C.M. Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 1985, 56:467-483.
33. Marzano A.V., Vezzoli P., Berti E. Skin involvement in cutaneous and systemic vasculitis. Autoimmun Rev 2013, 12:467-476.